Gary S. Figiel
- 2Articles
- 3.2KReads
- 2008Active
- 5Collaborators
- 14Citations
About
Gary S. Figiel has published research focused on the safety and efficacy of rivastigmine in patients with Alzheimer's disease, particularly those who have switched from or not responded adequately to donepezil. His work, appearing in 2008, addresses clinical aspects of dementia and neurology. He has frequently collaborated with authors including Barbara Koumaras, Ibrahim Gunay, John Strigas, Xiangyi Meng, and Carl H. Sadowsky.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
